Canaccord Upgrades Atara Biotherapeutics (ATRA) to Buy

May 8, 2026 4:29 AM

Canaccord analyst John Newman upgraded Atara Biotherapeutics (NASDAQ: ATRA) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found